Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study. Issue 4 (5th May 2018)

• Record Type: Journal Article
• Authors: Wang, Kun; Lu, Xue; Zhou, Hui; Gao, Yongyan; Zheng, Jian; Tong, Minghui; Wu, Changjun; Liu, Changzhu; Huang, Liping; Jiang, Tian'an; Meng, Fankun; Lu, Yongping; Ai, Hong; Xie, Xiao-Yan; Yin, Li-ping; Liang, Ping; Tian, Jie; Zheng, Rongqin
• Is Part Of: Gut. Volume 68:Issue 4(2019)
• Page Start: 729
• Page End: 741
• Publication Date: 2018-05-05
• Subjects: hepatitis B -- cirrhosis -- ultrasonography; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gutjnl-2018-316204
• Languages: English
• ISSNs: 0017-5749

Abstract

Abstract : Objective: We aimed to evaluate the performance of the newly developed deep learning Radiomics of elastography (DLRE) for assessing liver fibrosis stages. DLRE adopts the radiomic strategy for quantitative analysis of the heterogeneity in two-dimensional shear wave elastography (2D-SWE) images. Design: A prospective multicentre study was conducted to assess its accuracy in patients with chronic hepatitis B, in comparison with 2D-SWE, aspartate transaminase-to-platelet ratio index and fibrosis index based on four factors, by using liver biopsy as the reference standard. Its accuracy and robustness were also investigated by applying different number of acquisitions and different training cohorts, respectively. Data of 654 potentially eligible patients were prospectively enrolled from 12 hospitals, and finally 398 patients with 1990 images were included. Analysis of receiver operating characteristic (ROC) curves was performed to calculate the optimal area under the ROC curve (AUC) for cirrhosis (F4), advanced fibrosis (≥F3) and significance fibrosis (≥F2). Results: AUCs of DLRE were 0.97 for F4 (95% CI 0.94 to 0.99), 0.98 for ≥F3 (95% CI 0.96 to 1.00) and 0.85 (95% CI 0.81 to 0.89) for ≥F2, which were significantly better than other methods except 2D-SWE in ≥F2. Its diagnostic accuracy improved as more images (especially ≥3 images) were acquired from each individual. No significant variation of the performance was found if different training cohorts were applied. Conclusion: DLRE shows the best overall performance in predicting liver fibrosis stages compared with 2D-SWE and biomarkers. It is valuable and practical for the non-invasive accurate diagnosis of liver fibrosis stages in HBV-infected patients. Trial registration number: NCT02313649 ; Post-results.